Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JYP0066 in Mild-to-Moderate Atopic Dermatitis
NCT07843290Phase 2Not yet recruiting
- Sponsor
- Guangzhou JOYO Pharma
- Start
- Sep 2026
- Primary completion
- Aug 2027
01
Overview
A Phase 2 trial of JYP0066 in atopic dermatitis (AD), sponsored by Guangzhou JOYO Pharma. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
JYP0066
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT07843290.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07843290.